Kiora Pharmaceuticals
$1.95
46
+$0.02+1.04% Wednesday 18:53
Statistics
Day High
1.95
Day Low
1.92
52W High
4.18
52W Low
1.77
Volume
11,586
Avg. Volume
47,316
Mkt Cap
7.17M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
8MayExpected
Expected EPS
-0.71
Actual EPS
N/A
Financials
22.44%Profit Margin
Profitable32.04MRevenue
7.19MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow KPRX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Novavax
NVAX
Mkt Cap1.36B
Bausch Health Companies
BHC
Mkt Cap2.62B
Biogen
BIIB
Mkt Cap22.63B
Abbvie
ABBV
Mkt Cap385.18B
Pfizer
PFE
Mkt Cap140.15B
Johnson & Johnson
JNJ
Mkt Cap455.04B
Novartis
NVS
Mkt Cap237.61B
About
Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1 clinical trial that acts as a photoswitch to restore vision in patients with inherited and age-related degenerative retinal diseases. The company is also developing KIO-101, an eye drop that is in Phase 2 clinical trial for the treatment of ocular presentation of rheumatoid arthritis, as well as for treating non-infectious posterior uveitis; and KIO-201, an eye drop, which is in Phase 3 clinical trial for treating patients undergoing PRK surgery for corneal wound repair after refractive surgery. The company was formerly known as Eyegate Pharmaceuticals, Inc. and changed its name to Kiora Pharmaceuticals, Inc. in November 2021. Kiora Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Salt Lake City, Utah.
Show more...
CEO
Dr. Brian M. Strem Ph.D.
Employees
12
Country
US
ISIN
US49721T5074
Listings
0 Comments
Share your thoughts
FAQ
What is Kiora Pharmaceuticals stock price today?▼
The current price of KPRX is $1.95 USD — it has increased by +1.04% in the past 24 hours. Watch Kiora Pharmaceuticals stock price performance more closely on the chart.
What is Kiora Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Kiora Pharmaceuticals stocks are traded under the ticker KPRX.
Is Kiora Pharmaceuticals stock price growing?▼
KPRX stock has fallen by -1.02% compared to the previous week, the month change is a -5.34% fall, over the last year Kiora Pharmaceuticals has showed a -30.6% decrease.
What is Kiora Pharmaceuticals market cap?▼
Today Kiora Pharmaceuticals has the market capitalization of 7.17M
When is the next Kiora Pharmaceuticals earnings date?▼
Kiora Pharmaceuticals is going to release the next earnings report on May 08, 2026.
What were Kiora Pharmaceuticals earnings last quarter?▼
KPRX earnings for the last quarter are 0.01 USD per share, whereas the estimation was -0.74 USD resulting in a +101.36% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Kiora Pharmaceuticals revenue for the last year?▼
Kiora Pharmaceuticals revenue for the last year amounts to 32.04M USD.
What is Kiora Pharmaceuticals net income for the last year?▼
KPRX net income for the last year is 7.19M USD.
How many employees does Kiora Pharmaceuticals have?▼
As of April 02, 2026, the company has 12 employees.
In which sector is Kiora Pharmaceuticals located?▼
Kiora Pharmaceuticals operates in the Health Care sector.
When did Kiora Pharmaceuticals complete a stock split?▼
The last stock split for Kiora Pharmaceuticals was on June 11, 2024 with a ratio of 1:9.
Where is Kiora Pharmaceuticals headquartered?▼
Kiora Pharmaceuticals is headquartered in Encinitas, US.